Glenmark Rreceives Tentative ANDA Approval For Solifenacin Succinate Tablets

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Solifenacin Succinate Tablets, 5 mg and 10 mg, the generic version of Vesicare Tablets, 5 mg and 10 mg of the Astellas Pharma US Inc.

The Glenmark was trading higher by 1% at around Rs 635 per share. BSE Healthcare index was trading higher by 0.53% at 14,140 level. Sequent was the top gainer in the index trading higher by 4.6% at around Rs 125.7 per share. Other pharma stocks like Fortis, IOL Chemicals and Pharma, Alembic Pharma, Jubilant are also trading in the positive territory in the morning hours on Thursday.

Meanwhile, Nifty and Sensex were trading higher by more than a quarter percent in the morning hours on Thursday. Nifty is trading higher by 33 points and Sensex is trading higher by 128 points.

or Quick Trial – 8962000225 ✔ 
or mail us here:
or visit
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔
Share on Google Plus Share on Pinterest

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.